Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wall Street Media (WSM) is a digital media and broadcasting company that specializes in financial news, investor relations, and corporate communications. The company provides a platform for public companies, including those in the biotechnology and healthcare sectors, to reach investors through video interviews, press releases, and digital marketing services. WSM often features interviews with CEOs and executives from emerging life science companies to discuss clinical progress and corporate milestones. While it serves the healthcare industry as a service provider, it is not a therapeutic or clinical-stage biotech company itself.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wall Street Media.